Steineck, Isabelle I. K. http://orcid.org/0000-0001-5557-0885
Ranjan, Ajenthen
Schmidt, Signe
Clausen, Trine R.
Holst, Jens J.
Nørgaard, Kirsten
Funding for this research was provided by:
Zealand Pharma (NA)
Danish Diabetes Academy funded by the Novo Nordisk Foundation (NA)
Article History
Received: 20 August 2018
Accepted: 6 December 2018
First Online: 14 January 2019
Duality of interest
: None of the investigators has personal or financial interests in the conduct or the outcomes of the project. IIKS has received speaker grants from Roche Diabetes Care and Rubin Medical. SS has served on the continuous glucose monitoring advisory board of Roche Diabetes Care. JJH has consulted for Merck Sharp & Dome, Novo Nordisk and Roche. TRC works for Novo Nordisk A/S and own shares in Novo Nordisk A/S and Zealand Pharma A/S. KN serves as adviser to Medtronic, Abbott and Novo Nordisk A/S, owns shares in Novo Nordisk A/S, has received research grants from Novo Nordisk A/S and Roche Diabetes Care and has received fees for speaking from Medtronic, Roche Diabetes Care, Rubin Medical, Sanofi, Novo Nordisk A/S, Zealand Pharma and Bayer. AR declares that there is no duality of interest associated with his contribution to this manuscript.